Gevo's Ethanol Plant Sale Cuts $3 Million From Annual Expenses - Gevo ( NASDAQ:GEVO )
Gevo sells idle Luverne ethanol plant to A.E. Innovation for $7 million in staged payments. Oluwagbemileke Agiri appointed CFO as part of Gevo's long-term leadership succession plan. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for ...
Cortopia Announces Teenage Mutant Ninja Turtles: Empire City, First Ever TMNT VR Game
Last Ronin's Tom Waltz serving as story consultant STOCKHOLM, May 28, 2025 /PRNewswire/ -- The sewers are stirring. The rooftops are restless.
Troutman Pepper Locke Expands Government Contracts Practice with Partner Michael Barnicle
Former US Army Judge Advocate General's Corps Attorney Will Accelerate Growth in Federal Government Contracts and National Security Sectors Across Key Industries and Geographic Markets
ELV Investors Have the Opportunity to Lead the Elevance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Elevance Health ( NYSE:ELV )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Organon ( NYSE:OGN )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options
Pony AI Stock Plunges Wednesday: What's Going On? - Pony AI ( NASDAQ:PONY )
Pony AI shares dropped Wednesday, retreating after Tuesday's surge from Dubai expansion news. The decline may reflect profit-taking after a recent 76% month-long gain. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for Memorial Day.
Tempus Fugit, Investors Regret? Short Seller Targets AI Darling, Warns CEO Is 'Cash Out King' - Tempus AI ( NASDAQ:TEM )
Tempus AI shares are tumbling Wednesday morning after the company was targeted in a short report from Spruce Point. The short seller raises concerns around the company's management team and "suspicious" accounting practices.
A Penny Stock To Watch In Challenging Cancer Space - CytoDyn ( OTC:CYDY )
We have a $2.75 Price Target on CytoDyn ( CYDY ) in the Next 6 to 12 Months. The stock's current price is around $0.32. CytoDyn Inc. is a clinical-stage biotechnology company focused on developing leronlimab, a monoclonal antibody targeting the CCR5 receptor, with applications in HIV, ...
Nvidia Q1 Prediction Is In- Readers Nailed Tesla, Apple Results, Now 65% Say... - NVIDIA ( NASDAQ:NVDA )
Nvidia earnings will be closely watched by investors and analysts. A Benzinga poll shows investors predictions on Nvidia's Q1 earnings. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for Memorial Day.
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today - Carpenter Tech ( NYSE:CRS )
Carpenter Tech CRS has outperformed the market over the past 20 years by 3.16% on an annualized basis producing an average annual return of 11.44%. Currently, Carpenter Tech has a market capitalization of $11.95 billion.